A new panel made up of disabled young people is being organised by @DisRightsUK
Sounds like a really exciting opportunity for anyone interested under the age of 25!
Sign up below 👇
https://t.co/7ANCfVdpL6
We are excited to be at #AANEMinAustin to share two posters on our ongoing clinical trial in primary mitochondrial myopathy (PMM). Read the full abstracts for our posters (109 & 118) here: https://t.co/9MbXWCmgBM
With scientific evidence supporting mechanism for bilateral visual improvement with #genetherapy GS010 for #LHON#raredisease, @GensightBio plan to file for approval in Europe in Q3 2020 https://t.co/ZnOHFVPaq9 via @mdmagazine